Jubilant Pharmova : General updates

	July 14, 2022
BSE Limited,	National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers,	Exchange Plaza, 5th Floor,
Dalal Street, Fort,	Bandra-Kurla Complex,
Mumbai - 400 001	Bandra (E),
	Mumbai - 400051
Dear Sirs,

Sub: Early Redemption of 6% Senior Notes Due 2024 by Jubilant Pharma Limited, wholly- owned subsidiary of the Company (a company incorporated under the laws of Singapore)

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that our wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL') has given conditional notice to the holders of its US$200,000,000 6% Senior Notes due 2024 (the 'Notes') that it has elected to exercise its option to redeem US$200,000,000 in aggregate principal amount of the Notes on August 18, 2022 (the 'Redemption Date') pursuant to the terms of the indenture dated as of March 5, 2019 (the 'Indenture') between JPL and The Bank of New York Mellon, London Branch as trustee, governing the Notes. Following the proposed redemption of US$200,000,000, the Notes will be paid in full and no amount will remain outstanding under the Notes.

This notice of redemption is subject to and conditional upon the consummation of a certain Facility Agreement, by and among JPL, certain affiliates and subsidiaries of JPL and the financial institutions as lenders, and the funding of the loans contemplated thereunder. If such closing and funding does not occur on or prior to the Redemption Date, unless the Redemption Date is delayed pursuant to a notice from JPL to the trustee and paying agent, this notice of redemption shall be deemed to be rescinded and of no further force and effect.

Pursuant to the terms of the Indenture, the redemption price for the outstanding amount of the Notes will be equal to 103.00% of the principal amount of such Notes, plus accrued and unpaid interest thereon, to (but not including) the Redemption Date (the 'Redemption Price'). The payment of the Redemption Price in respect of the Notes will occur via the standard procedures of Euroclear and Clearstream. The Notes will be cancelled by JPL upon redemption.

This is for your information and record.

Thanking you,

Yours faithfully,

For Jubilant Pharmova Limited

RAJIV CHANDRAK ANT SHAH

Digitally signed by

RAJIV CHANDRAKANT SHAH

Date: 2022.07.14 14:54:58 +05'30'

Rajiv Shah Company Secretary